Ruth Taylor represents clients on private equity, M&A transactions, and portfolio matters.

Ruth advises financial sponsors, including private equity funds, their portfolio companies, and corporates on a broad range of corporate matters, including:

  • Domestic and cross-border mergers and acquisitions
  • Growth and minority investments
  • Consortium and joint venture arrangements
  • Management incentive schemes, restructurings, and other general corporate matters

Ruth’s experience includes advising:

  • Peak Rock Capital on acquiring Dalziel
  • A leading global asset manager on acquiring a large residential real estate portfolio
  • A European private equity firm on acquiring a leading UK-based medical device manufacturer and distributor
  • CVC on its carve-out acquisition of Smiths Detection Group
  • Nordic Capital on: 
    • Several acquisitions and ongoing MIP work for portfolio company Ascot Lloyd*
    • Several acquisitions for portfolio company Regnology*
    • Portfolio company Advanz Pharma’s acquisition of the majority of Intercept Pharmaceuticals*
    • Acquiring Care Fertility from Silverfleet and its subsequent acquisition of its US practice, REACH*
  • Archimed on:
    • Selling Direct Healthcare Group to Rhone Capital*
    • Acquiring Direct Healthcare Group from Northridge*
  • One Equity Partners on: 
    • Selling Brush Group’s Power Generator division to Baker Hughes*
    • Acquiring Brush Group from Melrose plc*
  • Titan Wealth/Parthenon Capital on acquiring IWP Financial Planning and IWP Investment Management*

*Matter handled prior to joining Latham

Bar Qualification

  • England and Wales (Solicitor)

Education

  • Graduate Diploma in Law, BPP University, 2017
  • Legal Practice Course, BPP University, 2017
  • BA in History, University of York, 2014

Languages Spoken

  • English